D2.1 - Glossary of terms and definitions used

Amy Rogers (Lead / Corresponding author), Rachel Copland (Lead / Corresponding author), Sonia Houston Pichardo (Lead / Corresponding author), Kate Harwood (Contributing member), Christa Müller-Vössing (Contributing member), Petra Naster (Contributing member), Linda Rutgrink (Contributing member), Ute Kohlhaas (Contributing member), Evert-Ben van Veen (Contributing member), Jozef Aerts (Contributing member), Bianca Schnalzer (Contributing member), Christoph Reiter (Contributing member), Robert Rehb (Contributing member)

Research output: Other contribution

Abstract

This document reports the processes used to develop a glossary of terms and definitions used within WP2 (task 2.1.1). The consortium agreed to expand the WP2 glossary to a project-level glossary since a common language should be established not only within but also across work packages. The aim of the glossary is to establish a common language within the project and to aid understanding of key terms that will feature in project outputs. The glossary itself, presented in the document, may be updated during the Trials@Home project so that important new terms can be added, obsolete terms removed, or existing terms updated to significant new insights. This approach has been chosen to reflect the fast-changing decentralised clinical trial landscape. The current version of the glossary can also be found online.
Original languageEnglish
TypeProject Deliverable - Glossary of Decentralised Clinical Trial terminology
Media of outputtext
PublisherTrials@Home
Number of pages12
Publication statusPublished - 28 Feb 2020

Fingerprint

Dive into the research topics of 'D2.1 - Glossary of terms and definitions used'. Together they form a unique fingerprint.

Cite this